Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Dongmei Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and chemical pharmaceuticals. Founded in 1996 and headquartered in Shijiazhuang, the company operates multiple GMP-certified production lines for various dosage forms, including oral liquids, tablets, and capsules. Its product portfolio is particularly strong in the respiratory and cardiovascular segments, with its "Dongmei" brand cough syrups being widely recognized in the domestic market. The company focuses on modernizing traditional herbal medicine through advanced extraction and formulation technologies to provide high-quality healthcare products. Dongmei Pharmaceutical is recognized as a high-tech enterprise in Hebei Province and maintains a significant presence in the Chinese generic drug market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dong Mei.